Biowell Boswellia
Natural health product licensed in Canada
- Other names
- Balaji Shallaki, Best Ayurveda Boswellia, Gayatri Ayurveda Shallaki, Shallaki, Vasishta Ayurvedic Boswellia
- Licence holder
- Biowell Laboratories
- NPN or DIN-HM
- 80071935
- Status
- Active licence
- Licence date
- 11 August 2016
- Revision date
- 6 March 2026
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Boswellia serrata Source : Stem bark oleogum resin Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 3,000 milligramme Potency : 40 Pour cent Boswellic acids | 300 milligramme | Not calculated |
| Boswellia serrata Source : Stem bark oleogum resin | Not specified | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Hydroxypropyl méthylcellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 3 Tous les jours |
Uses authorised in Canada
Helps to relieve joint pain and swelling associated with osteoarthritis of the knee.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity (e.g. allergy) has been known to occur; in which case, discontinue use. Some people may experience mild gastrointestinal disturbances such as diarrhoea, abdominal pain, heartburn, nausea and vomiting; in which case, discontinue use.
- Précautions et mises en garde
If you are pregnant or breastfeeding, consult a health care practitioner prior to use. If symptoms worsen, consult a health care practitioner.
Source
Official Health Canada record, licence 80071935
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.